Vehicular Impact Signaling Device
An apparatus for the deployment of a visible plume to alert other motorists that a proximate motor vehicle has been involved in a collision.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110200657 | METHODS OF USING NANOEMULSION COMPOSITIONS HAVING ANTI-INFLAMMATORY ACTIVITY Nanoemulsion compositions with low toxicity that demonstrate broad spectrum inactivation of microorganisms or prevention of diseases are described. The nanoemulsions contain an aqueous phase, an oil phase comprising an oil and an organic solvent, at least one anti-infla... | 08/18/2011 |
| 20100226983 | Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof The present invention relates to methods for treating and preventing acne or P. acnes infection in a subject comprising topically administering to the subject in need thereof an anti-acne nanoemulsion composition.... | 09/09/2010 |
| 20100092526 | NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., a... | 04/15/2010 |
| 20100075914 | METHODS FOR TREATING HERPES VIRUS INFECTIONS The present invention relates to methods for treating, killing, and/or inhibiting the growth of Herpes viruses in human subjects comprising topically administering to a human subject in need thereof a nanoemulsion composition having antiviral properties.... | 03/25/2010 |
| 20090304799 | NANOEMULSION INFLUENZA VACCINE The present invention relates to methods for inducing an immune response to influenza in a subject comprising administering a nanoemulsion vaccine composition comprising an influenza immunogen or protein.... | 12/10/2009 |
| 20090269394 | METHODS AND COMPOSITIONS FOR TREATING ONCHOMYCOSIS The present invention relates to methods for treating and completely curing fungal, yeast and/or mold infections in human subjects comprising topically administering to a human subject in need thereof an antifungal nanoemulsion composition.... | 10/29/2009 |
| 20090269380 | METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS The present invention relates to methods for treating and completely curing fungal, yeast, and/or mold infections in human subjects comprising topically administering to a human subject in need thereof an antifungal nanoemulsion composition.... | 10/29/2009 |
| 20070054834 | Quaternary ammonium halides for treatment of infectious conditions Compositions comprising quaternary ammonium halides and methods of using the compositions comprising quaternary ammonium halides to treat and/or prevent infectious conditions in humans are provided. ... | 03/08/2007 |
| 20070036831 | Nanoemulsion compositions having anti-inflammatory activity Nanoemulsion compositions with low toxicity that demonstrate broad spectrum inactivation of microorganisms or prevention of diseases are described. The nanoemulsions contain an aqueous phase, an oil phase comprising an oil and an organic solvent, at least one anti-infla... | 02/15/2007 |
| 20060251684 | Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof Nanoemulsion compositions with low toxicity that demonstrate broad spectrum inactivation of microorganisms or prevention of diseases are described. The nanoemulsions contain an aqueous phase, an oil phase comprising an oil and an organic solvent, and one or more surfact... | 11/09/2006 |
| 20050208083 | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof Nanoemulsion compositions with low toxicity that demonstrate broad spectrum inactivation of microorganisms or prevention of diseases are described. The nanoemulsions contain an aqueous phase, an oil phase comprising an oil and an organic solvent, and one or more surfact... | 09/22/2005 |